Search filters

List of works by Xavier Preville

6-Methylprednisolone does not impair anti-thymocyte globulin (ATG) immunosuppressive activity in non-human primates

scientific article published in October 2001

A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG).

scientific article

A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.

scientific article published on 15 July 2013

Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis

scientific article published in November 2014

Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion

scientific article published on 31 July 2003

Chemical labels metabolically installed into the glycoconjugates of the target cell surface can be used to track lymphocyte/target cell interplay via trogocytosis: comparisons with lipophilic dyes and biotin.

scientific article published in January 2007

Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts.

scientific article published on January 1995

Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.

scientific article published in January 2005

Fc-γ receptor-mediated crosslinking co-defines the immunostimulatory activity of anti-human CD96 antibodies

scientific article published in 2022

First human hand transplantation. Case report

scientific article published on 01 January 2000

Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins1

scientific article published on 01 March 2003

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

scientific article published on 23 May 2017

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes

scientific article published on 02 May 2017

Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein

scientific article published on 04 December 2013

Improving administration regimens of CyaA-based vaccines using TRAP assays to detect antigen-specific CD8(+) T cells directly ex vivo.

scientific article

Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist.

scientific article published on 28 August 2014

Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial treatment with a TLR9 agonist

article published in 2014

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

scientific article published on 01 February 2001

Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment

scientific article published on 6 October 2015

Phosphorylation is not essential for protection of L929 cells by Hsp25 against H2O2-mediated disruption actin cytoskeleton, a protection which appears related to the redox change mediated by Hsp25.

scientific article

Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation

scientific article (publication date: 2 July 1999)

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model ⬇️

scientific article published on 19 September 2017

Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.

scientific article published on 21 December 2016

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand.

scientific article published on 3 February 2015

TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy.

scientific article

TNF alpha and CD95-L contribute to apoptosis of activated lymphocytes triggered by ATGs

scientific article published on 01 February 1999

Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts

scientific article

Trial Watch-Oncolytic viruses and cancer therapy

scientific article

Trial Watch:: Oncolytic viruses for cancer therapy

scientific article

Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine

scientific article published in June 1995

Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer

scientific article published on 12 December 2016

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition

scientific article published on 09 September 2016

Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC

scientific article published on 19 September 2017

Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy.

scientific article published on 26 February 2014

Paulina is supported by:

About Paulina

Help